Overexpression of telomerase-associated chaperone proteins in prostatic intraepithelial neoplasia and carcinomas

被引:17
作者
Elmore, Lynne W. [1 ]
Forsythe, Robert [1 ]
Forsythe, Heidi [1 ]
Bright, A. Taylor [1 ]
Nasim, Suhail [1 ]
Endo, Kanendori [1 ]
Holt, Shawn E. [1 ,2 ,3 ,4 ]
机构
[1] Virginia Commonwealth Univ, Coll Med, Dept Pathol, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Coll Med, Dept Human Genet, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Coll Med, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
[4] Virginia Commonwealth Univ, Coll Med, Massey Canc Ctr, Richmond, VA 23298 USA
关键词
chaperones; hsp90; p23; telomerase; hTERT; prostate cancer; prostatic intraepithetial neoplasia;
D O I
10.3892/or_00000049
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Over 90% of prostate cancers express telomerase activity. In an experimental model, hsp90 and p23, which are necessary for telomerase assembly and function, dramatically increase during tumorigenic conversion. We immunohistochemically analyzed 60 prostate carcinomas, 50 prostatic intraepithelial neoplasias (PIN) and 25 benign prostatic tissues to determine whether hsp90/p23 expression correlates with advancing stage and whether chaperone distribution overlaps with hTERT, the catalytic component of telomerase. Strong expression of hsp90/p23 was detected in similar to 95% of PIN and carcinomas without relationship to Gleason score. While hsp90/p23 immunostaining was predominantly diffuse and cytoplasmic, nuclear immunoreactivity was observed in several moderate-to-high grade carcinomas, and those carcinomas with nuclear chaperone staining exhibited detectable hTERT. Our data suggest enhanced chaperone-mediated telomerase assembly as a mechanism for increased activity in advanced prostate carcinomas, stable association between chaperones and telomerase in vivo, and utility for chaperone immuno-staining to identify focal PIN in the context of widespread hyperplasia.
引用
收藏
页码:613 / 617
页数:5
相关论文
共 20 条
[1]  
Akalin A, 2001, CANCER RES, V61, P4791
[2]  
Felts SJ, 2003, CELL STRESS CHAPERON, V8, P108, DOI 10.1379/1466-1268(2003)008<0108:PASPWC>2.0.CO
[3]  
2
[4]   THE RNA COMPONENT OF HUMAN TELOMERASE [J].
FENG, JL ;
FUNK, WD ;
WANG, SS ;
WEINRICH, SL ;
AVILION, AA ;
CHIU, CP ;
ADAMS, RR ;
CHANG, E ;
ALLSOPP, RC ;
YU, JH ;
LE, SY ;
WEST, MD ;
HARLEY, CB ;
ANDREWS, WH ;
GREIDER, CW ;
VILLEPONTEAU, B .
SCIENCE, 1995, 269 (5228) :1236-1241
[5]   Stable association of hsp90 and p23, but not hsp70, with active human telomerase [J].
Forsythe, HL ;
Jarvis, JL ;
Turner, JW ;
Elmore, LW ;
Holt, SE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (19) :15571-15574
[6]   The Hsp90 chaperone complex as a novel target for cancer therapy [J].
Goetz, MP ;
Toft, DO ;
Ames, MM ;
Erlichman, C .
ANNALS OF ONCOLOGY, 2003, 14 (08) :1169-1176
[7]   Functional requirement of p23 and Hsp90 in telomerase complexes [J].
Holt, SE ;
Aisner, DL ;
Baur, J ;
Tesmer, VM ;
Dy, M ;
Ouellette, M ;
Trager, JB ;
Morin, GB ;
Toft, DO ;
Shay, JW ;
Wright, WE ;
White, MA .
GENES & DEVELOPMENT, 1999, 13 (07) :817-826
[8]   Telomerase reverse transcriptase subunit immunoreactivity - A marker for high-grade prostate carcinoma [J].
Iczkowski, KA ;
Pantazis, CG ;
McGregor, DH ;
Wu, YP ;
Tawfik, OW .
CANCER, 2002, 95 (12) :2487-2493
[9]   ALG-2:: a Ca2+-binding modulator protein involved in cell proliferation and in cell death [J].
Krebs, J ;
Saremaslani, P ;
Caduff, R .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2002, 1600 (1-2) :68-73
[10]   Expression of major heat shock proteins in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy [J].
Kurahashi, Toshifumi ;
Miyake, Hideaki ;
Hara, Isao ;
Fujisawa, Masato .
JOURNAL OF UROLOGY, 2007, 177 (02) :757-761